Emily Vandenbroucke
Senior Director, Digital Innovation @Lantheus
Signup · Get unlimited contacts
WORK HISTORY
Senior Director, Digital Innovation @Lantheus
Define and execute AI-enabled software as medical device (SaMD) strategy to support and differentiate the molecular imaging portfolio across the product lifecycle. • Drive integration of quantitative imaging capabilities across neurology, oncology, and cardiology programs to strengthen portfolio positioning and long-term asset value. • Identify and advance potential new imaging tracer opportunities within innovation and strategy initiatives. • Lead strategic collaborations with pharma, academia, and biotech to apply AI-enabled imaging solutions that advance molecular imaging and expand the impact of the diagnostic portfolio.
EDUCATION
Miami University
BA, Zoology/Medical Science and Psychology
University of Illinois Chicago
PhD, Pharmacology
ABOUT EMILY VANDENBROUCKE
Senior clinical leader with 13+ years of experience advancing radiopharmaceutical and medical device programs across cardiology, oncology, and neurology. Currently lead AI-enabled software as medical device (SaMD) strategy, applying quantitative analytics to complement radiotracer development programs and contributing to evaluation of novel imaging assets and portfolio expansion initiatives. Experience leading global Phase 1–3 development programs across US and European regulatory pathways and building high-performing, cross-functional teams. Driven by a long-standing focus in radiodiagnostics and a commitment to advancing the field through development of differentiated tracers that address clear unmet clinical needs. Motivated to apply experience across clinical, regulatory, and medical strategies to support thoughtful evaluation and successful advancement of novel molecular imaging assets.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.